MX2010001421A - Dializado peritoneal. - Google Patents

Dializado peritoneal.

Info

Publication number
MX2010001421A
MX2010001421A MX2010001421A MX2010001421A MX2010001421A MX 2010001421 A MX2010001421 A MX 2010001421A MX 2010001421 A MX2010001421 A MX 2010001421A MX 2010001421 A MX2010001421 A MX 2010001421A MX 2010001421 A MX2010001421 A MX 2010001421A
Authority
MX
Mexico
Prior art keywords
peritoneal
dialysis treatment
peritoneal dialysate
dialysate
renal
Prior art date
Application number
MX2010001421A
Other languages
English (en)
Inventor
Yasumi Yugari
Tsutomu Sanaka
Original Assignee
Cheiron Japan Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cheiron Japan Co filed Critical Cheiron Japan Co
Publication of MX2010001421A publication Critical patent/MX2010001421A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Esta invenci?n proporciona un dializado peritoneal seguro y altamente estable, que no causa des?rdenes de membrana peritoneal ni esclerosis peritoneal asociada con el tratamiento de di?lisis peritoneal frecuentemente repetido, que puede proteger las funciones renales residuales en la talla renal cr?nica, que inhibe el progreso del da?o renal durante un per?odo largo de tiempo, y que permite el tratamiento de di?lisis peritoneal de pacientes diab?ticos. Este dializado peritoneal contiene 0.05 a 3.5 p/v% de taurina y 0.1 a 6.5 p/v% de trehalosa como agentes osm?ticos y tiene un valor de pH ajustado entre 6.5-7.5.
MX2010001421A 2007-08-15 2007-08-15 Dializado peritoneal. MX2010001421A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2007/065911 WO2009022417A1 (ja) 2007-08-15 2007-08-15 腹膜透析液

Publications (1)

Publication Number Publication Date
MX2010001421A true MX2010001421A (es) 2010-04-09

Family

ID=40350481

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010001421A MX2010001421A (es) 2007-08-15 2007-08-15 Dializado peritoneal.

Country Status (10)

Country Link
US (1) US20100187476A1 (es)
EP (1) EP2177225A4 (es)
JP (1) JP4224117B1 (es)
KR (1) KR101457055B1 (es)
CN (1) CN101861153A (es)
AU (1) AU2007357726A1 (es)
BR (1) BRPI0721897A2 (es)
CA (1) CA2695176A1 (es)
MX (1) MX2010001421A (es)
WO (1) WO2009022417A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103619372A (zh) 2011-03-23 2014-03-05 纳科斯达格医药股份有限公司 腹膜透析系统、装置和方法
US9861733B2 (en) 2012-03-23 2018-01-09 Nxstage Medical Inc. Peritoneal dialysis systems, devices, and methods
CN102973600B (zh) * 2012-12-13 2014-11-26 天津金耀集团有限公司 一种腹膜透析液（乳酸盐）（低钙）组合物
WO2014180959A1 (en) 2013-05-08 2014-11-13 Gambro Lundia Ab Dialysis formulation
CN104666337A (zh) * 2013-11-27 2015-06-03 天津金耀集团有限公司 一种腹膜透析液(乳酸盐)(低钙)组合物
CN104666335A (zh) * 2013-11-27 2015-06-03 天津金耀集团有限公司 一种腹膜透析液(乳酸盐)(低钙)组合物的制备方法
CN104666331A (zh) * 2013-11-27 2015-06-03 天津金耀集团有限公司 一种腹膜透析液(乳酸盐)组合物
CN103816182B (zh) * 2014-02-26 2016-05-25 四川大学华西医院 一种血液滤过置换液及其制备方法
DE102014013885A1 (de) * 2014-09-18 2016-03-24 Fresenius Medical Care Deutschland Gmbh Dialyselösung
CN105640947A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 碱性必需氨基酸乳酸盐腹膜透析液药物组合物
CN105640983A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 碱性氨基酸（15）乳酸盐腹膜透析液药物组合物
CN105560231A (zh) * 2014-11-10 2016-05-11 天津金耀集团有限公司 碱性低钙氨基酸（15）腹膜透析液药物组合物
CN105560275A (zh) * 2014-11-10 2016-05-11 天津金耀集团有限公司 碱性低钙必需氨基酸腹膜透析液药物组合物
EP3352586A4 (en) 2015-09-21 2019-05-15 The Board Of Trustees Of The Leland Stanford Junior University NUTRITIONAL ANTICANCER TREATMENT
WO2019118519A1 (en) * 2017-12-11 2019-06-20 Filtricine, Inc. Compositions, methods, kits and systems for cancer treatment and metabolic intervention therapy
AU2019228526B2 (en) 2018-02-28 2021-11-25 Nxstage Medical, Inc. Fluid preparation and treatment devices, methods, and systems

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3821043A1 (de) * 1988-06-22 1989-12-28 Fresenius Ag Dialysier- und spuel-loesung zur intraperitonealen verabreichung
US6306836B1 (en) * 1994-01-21 2001-10-23 Baxter International Inc. Peritoneal dialysis solutions containing maltodextrins and amino acids
JP3589701B2 (ja) * 1994-05-31 2004-11-17 味の素ファルマ株式会社 トレハロース含有腹膜透析液
AU8898898A (en) * 1997-08-07 1999-03-01 Ajay Gupta Dialysis solutions containing water soluble vitamins and nutrients
JP3871442B2 (ja) 1998-08-11 2007-01-24 テルモ株式会社 腹膜透析液
JP2002282354A (ja) 2001-03-27 2002-10-02 Jms Co Ltd 腹膜透析液
US20030217369A1 (en) * 2002-05-17 2003-11-20 Heredia Edwin Arturo Flexible application information formulation
AU2003238691A1 (en) * 2002-07-01 2004-01-19 Jms Co., Ltd. Peritoneal dialysate containing taurine
KR100689479B1 (ko) * 2005-02-15 2007-03-02 삼성전자주식회사 디지털 방송을 위한 전자 프로그램 가이드 제공 방법
KR101358850B1 (ko) * 2007-03-23 2014-02-05 삼성전자주식회사 방송 수신 장치 및 방송 수신 장치에서 애플리케이션을실행하는 방법

Also Published As

Publication number Publication date
BRPI0721897A2 (pt) 2015-04-07
KR20100045496A (ko) 2010-05-03
KR101457055B1 (ko) 2014-10-31
WO2009022417A1 (ja) 2009-02-19
US20100187476A1 (en) 2010-07-29
EP2177225A4 (en) 2010-11-24
CA2695176A1 (en) 2009-02-19
EP2177225A1 (en) 2010-04-21
CN101861153A (zh) 2010-10-13
AU2007357726A1 (en) 2009-02-19
JP4224117B1 (ja) 2009-02-12
JPWO2009022417A1 (ja) 2010-11-11

Similar Documents

Publication Publication Date Title
MX2010001421A (es) Dializado peritoneal.
MX2009011898A (es) Composiciones y metodos para tratar trastornos asociados con retencion de sal o fluido.
BR122019014539B8 (pt) sistemas de hemodiálise
PH12015502275B1 (en) Therapuetic uses of empagliflozin
NZ604063A (en) Compositions and methods for enhancing physiological performance and recovery time
WO2009044919A1 (ja) 安定な炭酸水素イオン含有薬液
EA201201284A1 (ru) Система для обработки крови
GB201201330D0 (en) Dialysis machine
WO2009149002A3 (en) "customizable personal dialysis device having ease of use and therapy enhancement features"
WO2006119958A3 (en) Use of flibanserin in the treatment of chronic pain
WO2007085021A3 (en) Methods of treating or preventing peritonitis with oxidative reductive potential water solution
MY153408A (en) Novel methods
TW200637842A (en) Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as a medicament and medicament comprising them
WO2018106185A3 (en) Sorbent for a dialysis device and dialysis system
MX2019013861A (es) Metodos y sistemas para eliminar dioxido de carbono.
MX2015001508A (es) El uso de antitrombina en la oxigenacion por membrana extracorporea.
MX2015001019A (es) Preparacion para tratamiento de heridas y llagas que comprende hipoclorito y aminoacidos.
MA32480B1 (fr) Compositions pédiatriques pour le traitement de la sclérose en plaques
MX2011009804A (es) Una dosis de ave5026 para el tratamiento de tromboembolismo venoso en pacientes con deterioro renal severo.
EA201200181A1 (ru) Защита клеток пациентов на диализе путём введения соединений креатина
IL185807A0 (en) Use of amino-substituted benzimidazoles
DK1732551T3 (da) Perhexilin til behandling af kronisk hjertesvigt
EP1997503A3 (en) Treatment of melanoma with alpha thymosin peptides
MX2007003120A (es) Metodo y composicion para el tratamiento de pacientes que se someten a dialisis de rinon.
WO2010075444A3 (en) Nasal formulations of metoclopramide

Legal Events

Date Code Title Description
FG Grant or registration